The Company Also Gains
Worldwide Non-Exclusive Rights to Sell
Can-C and Melatonin (MZS) from Antiaging
Systems Ltd.
San
Diego, CA -- January 18, 2018 -- InvestorsHub NewsWire
-- Innovus Pharmaceuticals, Inc. ("Innovus Pharma"
or the
"Company") (OTCQB Venture
Market: INNV), an emerging
over-the-counter ("OTC") consumer goods and specialty
pharmaceutical company engaged in the commercialization, licensing
and development of safe and effective non-prescription medicine and
consumer care products to improve men's and women's health and
vitality and respiratory diseases, today
announced the
official
launch of
its Amazon,
Walmart, eBay
and
Wish on-line
stores
in the
United States with
a
combined 116
Company
product SKUs.
As part
of this on-line product distribution, the Company
also
secured
worldwide non-exclusive rights
to sell two primary
products from Antiaging Systems, Ltd.: Can-C
and
Melatonin (MZS).
The launch of the
U.S. on-line
stores
adds to
Innovus Pharma's substantial on-line sales
presence and expands
its
other
on-line
websites
and its Beyond Human
platform,
which
currently
include
over 160
websites and over 2.5 million subscribers.
"We are very excited
to announce the official launch of our Amazon,
Walmart, eBay and Wish
on-line stores with
our
current combined 116
product
SKUs,"
said Innovus CEO Dr. Bassam Damaj. "We are already
seeing a significant
increase
in our month over month sales from the on-line stores and we
currently
expect
the on-line sales to be a growing
percentage of our
revenues in the very near future."
"In addition, we are
working on the development and launch of additional Amazon
sites in
Canada, Mexico and the United Kingdom and we look forward to
growing our on-line presence of our products and additional
products such as Can-C and Melatonin
(MZS)
that
already have large on-line sales presences with Can-C
alone
generating
on
average across all
sellers on Amazon
around
$1.2 million per year in 2017. These additional
sales channels should only serve to increase the overall sales
revenues we may see in the future through our ever-growing
online
channels," he continued.
About Can-C
Eye Drops
Can-C eye drops, made
by Antiaging Systems, Ltd., are the
original N-acetylcarnosine (often shorted to "NAC")
eye drop formula developed to normalize senile cataract impairment.
Users and
scientists have reported that Can-C is also great
for:
- Dry eye
syndrome.
- Benefit for those who
wear contact lenses, particularly soft contact lenses. (Not only do
the lubricants in Can-C help contact lenses feel
more
comfortable, but N-acetylcarnosine is also believed to inhibit
the buildup
of lactic
acid in the eye, meaning you can wear them in comfort for
longer.)
- Corneal
disorders.
- Computer vision
syndrome.
- Eye
strain.
- Ocular
inflammation.
- Blurred
vision.
- Presbyopia.
- Retinal
diseases.
- Vitreous opacities
and lesions.
- Complications of
diabetes mellitus and other systemic diseases.
- Open-angle primary
glaucoma.
Cataract
surgery is the most commonly performed operation in the world with
over 1.5 million
operations in the
United States alone every year.
Although generally safe, there is still a
complication rate of 30% to 50% of patients
who develop opacification of the posterior lens capsule within two
years and require further laser
treatment. Can-C
cataract eye drops have helped thousands of people
normalize
their
cataracts without surgery, leaving the natural lens in place rather
than an artificial one.
Human trials on
people suffering from senile cataract, using a twice daily dose of
Can-C for six months showed the following results:
- 88.9
percent of patients had
improved glare sensitivity;
- 90 percent reported
improved visual acuity clearer and sharper
vision;
and
- Perhaps
most significantly, 41 percent of patients
experienced a significant improvement in lens
'transmissivity'.
And while the
patients were taking the NAC carnosine eye
drops, the
lead researcher noted that there was no recurrence of
cataract.
About Melatonin
(MZS)
Melatonin (MZS) is
made by Antiaging Systems Ltd. and
its main
ingredient, melatonin, is vital to protect a
person's hormonal system, regulate immunity and repair
the
body's
cells.
It is commonly used
by shift workers and also to treat jet lag and age-related sleep
disorders, but its abilities go far beyond simply its
sleep-inducing properties. Other benefits of the product are its
use as an antioxidant, for longevity and for age related macular
degenerations.
Melatonin's effect on longevity is well documented; in fact
laboratory tests on rats and mice have demonstrated that melatonin
increased their lifespans by 20%. Numerous experts
believe
melatonin is a vital anti-aging product because of its positive
effect on the aging immune
system,
its protection of the cardiovascular system, its ability to
increase growth hormone production and above all its capacity to
limit free radical damage.
About Innovus
Pharmaceuticals, Inc.
Headquartered in San
Diego, Innovus Pharma is an emerging OTC consumer goods and
specialty pharmaceutical company engaged in the commercialization,
licensing and development of safe and effective non-prescription
medicine and consumer care products to improve men's and women's
health and vitality and respiratory diseases. Innovus Pharma
delivers innovative and uniquely presented and packaged health
solutions through its (a) OTC medicines and consumer and health
products, which we market directly, (b) commercial partners to
primary care physicians, urologists, gynecologists
and therapists, and (c) directly to consumers through our on-line
channels, retailers and wholesalers. The Company is dedicated to
being a leader in developing and marketing new OTC and branded
Abbreviated New Drug Application ("ANDA") products. The Company is
actively pursuing opportunities where existing prescription drugs
have recently, or are expected to, change from prescription (or Rx)
to OTC.
For more information,
go to www.innovuspharma.com; www.zestra.com; www.ejectdelay.com; www.myvesele.com;
www.urivarx.com; www.sensumplus.com; www.myandroferti.com; www.beyondhumantestosterone.com; www.getbeyondhuman.com; www.trybeyondhuman.com; www.recalmax.com;
www.prostagorx.com;
www.fluticare.com;
www.allervarx.com;
and
www.apeaz.com.
Amazon is a
registered trademark of Amazon.com,
Inc. (NASDAQ:
AMNZ); eBay
is a
registered trademark of eBay,
Inc.
(NASDAQ:
EBAY); Walmart is a registered
trademark of Wal-mart
Stores,
Inc. (NYSE: WMY);
and
Wish
is
a registered
trademark
of ContextLogic,
Inc.
Innovus Pharma's
Forward-Looking Safe Harbor:
Statements under the
Private Securities Litigation Reform Act, as amended: with the
exception of the historical information contained in this release,
the matters described herein contain forward-looking statements
that involve risks and uncertainties that may individually or
mutually impact the matters herein described for a variety of
reasons that are outside the control of the Company, including, but
not limited to, projected revenues from the sales of its products
through its Amazon stores and through
its other on-line channels,
estimated market for its
products, and statements about
achieving its other development, growth, commercialization,
financial and staffing objectives. Readers are cautioned
not to place undue reliance on these forward-looking statements as
actual results could differ materially from the forward-looking
statements contained herein. Readers are urged to read the risk
factors set forth in the Company's most recent
filing on Form S-1, annual report on Form 10-K, subsequent
quarterly reports filed on Form 10-Q and other filings made with
the SEC. Copies of these reports are available from the SEC's
website or without charge from the Company.
###
Contact:
James S. Painter
III
Emerging Markets
Consulting, LLC
Tel:
407
340
0226
jamespainter@emergingmarketsllc.com